Hancock Classic Value's Top Holdings Snapshot: Focus on Healthcare and Technology
Richard Pzena's Hancock Classic Value fund, as of March 31, 2026, holds significant positions in consumer cyclical, healthcare, and technology sectors, with notable changes in shares for several stocks.
As of March 31, 2026, Richard Pzena's Hancock Classic Value fund maintains a substantial portfolio with a total value exceeding $30 billion. The fund's top holdings are concentrated in sectors like Healthcare, Technology, and Consumer Cyclical, reflecting Pzena's investment strategy.
Magna International (MGA), a key holding in the Consumer Cyclical sector, represents approximately 6.39% of the portfolio. The position saw a reduction of 13% in shares compared to the previous period.
Healthcare remains a significant sector for the fund, with Bristol Myers Squibb (BMY) and CVS Health (CVS) each accounting for around 3.37% and 3.21% of the portfolio, respectively. Both positions experienced declines, with BMY seeing an 8.72% reduction in shares and CVS a 11.61% reduction.
Baxter International (BAX) is another major Healthcare holding at 3.52% allocation, though it also saw a decline of 7.88% in shares.
Humana (HUM) stands out among Healthcare stocks with a significant increase of 34.35% in shares during the period, now comprising 3.08% of the portfolio.
Financial Services allocation includes Capital One (COF) at 2.71% and Citi (C) at 3.01%, both showing reductions of 8.78% and 22.98% in shares, respectively.
Technology sector representation comes from Cognizant (CTSH) and Skyworks Solutions (SWKS), holding 4.04% and 2.8% of the portfolio. SWKS saw a particularly strong increase with a 27.57% rise in shares.
For detailed analysis of these holdings and the fund itself, readers can explore the investor profile at https://www.insiderset.com/investor/richard-pzena-hancock-classic-value and individual stock profiles at https://www.insiderset.com/investors/stocks/.